Search results for: 'software as a service transaction'

The cardiac monitoring market will benefit from healthcare delivery challenges by promoting advanced monitoring solutions that help providers reduce 30-day readmissions for cardiac-associated conditions. Interest in the remote patient monitoring space is altering portfolio approaches across products and services. Changes in payments, particularly g...

Over the past 2 years the global pharmaceutical industry has been shifting its focus towards the emerging market such as India. The CRAMS segment in India is expected to be one of the biggest beneficiaries of this wave. This study presents a comprehensive study of the Indian contract research and manufacturing services market from drug discovery t...

In this analysis, Frost & Sullivan provides critical insights into the biotech M&A and venture capital (VC) investment, highlighting the drivers, challenges, predictions, and major trends in the biotech segment. This analysis also identifies actionable growth opportunities for industry participants to leverage. To understand the trend outlook fo...

The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity. Overall R&D expenditure totals about $276....

Retail technology investment in Australia is projected to record a CAGR of 28.8% from 2016-2021 largely driven by evolving consumer requirements and intensifying retail competition from international entrants and new business models. These factors are set to raise standards across both the front and back ends of retail technology. Current investmen...

Accelerated reforms due to COVID-19 and technologically advanced sample-in-answer-out portable, web-connected, encrypted devices that provide results in a few minutes changed the diagnostic healthcare industry. Decentralized testing empowers clinicians to make lifesaving decisions for the patient. It shortens supply chain lag time, saves costs of i...

20 Mar 2019  |  North America  |  Market Research

Growth Opportunities in the North American Clinical Laboratory Services Market, Forecast to 2022

Laboratories Seek Alternate Revenue Streams to Combat Reimbursement Pressure

Infographics

×

Clinical laboratory services represent one of the highest healthcare expenditures in North America, yet the United States and Canada represent different scenarios in the way clinical services are rendered. The market for clinical lab services in Canada was an estimated $10.33 billion in 2017 whereas in the United States it was an estimated $78.33 b...

This industry docket assess Nepal's healthcare market and highlights investment opportunities therein. The country lacks centers of excellence in tertiary care leading to outflow of patients seeking the same. Nepal is currently seeing increasing investment by private and corporate hospital sectors in speciality services like Cardiac Sciences, Neu...

The clinical laboratory testing industry will continue to experience growth in testing volumes due to the aging of the US population, patient awareness of the benefits of laboratory testing, test cost reductions, the development of advanced and specialized tests for disease detection and management, the growing awareness of early detection and prev...